Overview

Atorvastatin in Patients With Ulcerative Colitis

Status:
Not yet recruiting
Trial end date:
2027-06-20
Target enrollment:
Participant gender:
Summary
Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease characterized by diffused inflammation of the colon and rectum mucosa; however, the exact underlying mechanisms of UC remain poorly understood. Statins exert numerous pleiotropic effects including anti-inflammatory, antioxidant properties, endothelial function improvement, and immunomodulation independent of their basic lipid-lowering property.
Phase:
Phase 2
Details
Lead Sponsor:
Tanta University
Treatments:
Atorvastatin